5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.36▲ | 1.37▼ | 1.38▼ | 1.37▼ | 1.75▼ |
MA10 | 1.37▼ | 1.37▼ | 1.39▼ | 1.65▼ | 1.89▼ |
MA20 | 1.37▼ | 1.39▼ | 1.40▼ | 1.84▼ | 1.86▼ |
MA50 | 1.37▼ | 1.39▼ | 1.53▼ | 1.94▼ | 3.52▼ |
MA100 | 1.39▼ | 1.57▼ | 1.81▼ | 1.90▼ | 5.68▼ |
MA200 | 1.40▼ | 1.82▼ | 1.96▼ | 2.85▼ | 18.90▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.001▼ | 0.008▲ | -0.078▼ | 0.104▲ |
RSI | 42.810▼ | 39.532▼ | 34.689▼ | 32.486▼ | 33.342▼ |
STOCH | 8.333▼ | 42.530 | 37.908 | 6.778▼ | 43.742 |
WILL %R | -75.000▼ | -69.231 | -84.000▼ | -93.993▼ | -94.203▼ |
CCI | -69.771 | -150.633▼ | -103.704▼ | -80.881 | -180.000▼ |
Friday, July 11, 2025 02:28 PM
This was the stock's second consecutive day of losses.
|
Thursday, July 10, 2025 02:27 PM
The stock's fall snapped a two-day winning streak.
|
Wednesday, July 09, 2025 08:58 AM
Inovio Pharmaceuticals (NASDAQ:INO) stock rises as Piper Sandler issues new Overweight rating, citing FDA approval for its lead drug INO-3107 next year. Read more here.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 1.37 | 1.40 | 1.34 | 1.36 | 1,788,861 |
10/07/25 | 1.47 | 1.47 | 1.38 | 1.39 | 2,607,899 |
09/07/25 | 1.36 | 1.46 | 1.35 | 1.45 | 5,286,609 |
08/07/25 | 1.36 | 1.38 | 1.32 | 1.34 | 2,676,484 |
07/07/25 | 1.45 | 1.45 | 1.30 | 1.33 | 9,364,000 |
03/07/25 | 1.51 | 1.54 | 1.30 | 1.33 | 21,094,885 |
02/07/25 | 2.02 | 2.25 | 1.98 | 2.14 | 1,923,265 |
01/07/25 | 2.02 | 2.145 | 1.93 | 2.04 | 853,421 |
30/06/25 | 2.15 | 2.18 | 2.02 | 2.035 | 912,387 |
27/06/25 | 2.25 | 2.265 | 2.02 | 2.11 | 4,786,648 |
|
|
||||
|
|
||||
|
|